EW vs BSX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BSX Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Options & Structure while EW counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus BSX at 14.2x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (53rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EW Revenue | BSX Revenue | EW Op. Margin | BSX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $3.72B | $9.82B | 20.1% | 15.3% | EW |
| FY2019 | $4.35B | $10.7B | 26.4% | 14.1% | EW |
| FY2020 | $4.39B | $9.91B | 20.5% | -0.8% | EW |
| FY2021 | $5.23B | $11.9B | 32.3% | 10.1% | EW |
| FY2022 | $4.46B | $12.7B | 33.6% | 13.0% | EW |
| FY2023 | $5.01B | $14.2B | 26.1% | 16.5% | EW |
| FY2024 | $5.44B | $16.8B | 25.3% | 15.5% | EW |
| FY2025 | $6.07B | $20.1B | 20.8% | 18.0% | EW |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EW | BSX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $60.8B | $64.1B | Larger Scale | BSX |
| Trailing P/E Ratio Valuation | 61.5x | 18.6x | Lower Multiple | BSX |
| Forward P/E Ratio Valuation | 31.6x | 14.2x | Lower Multiple | BSX |
| Revenue Growth (YoY) Growth | +10.5% | +1.4% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 28.8% | 19.6% | Higher Margin | EW |
| Net Profit Margin Profitability | 15.3% | 16.6% | Higher Margin | BSX |
| Return on Equity (ROE) Capital Efficiency | 9.3% | 14.1% | Higher ROE | BSX |
| 52-Week Range Position Momentum | 96% ($75โ$108) | 6% ($40โ$106) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 24% Vol | 0.32ฮฒ ยท 45% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 58.8 / 100 (HOLD) | Higher Composite | BSX |